Avidity Biosciences Inc (RNA)
42.55
-1.10
(-2.52%)
USD |
NASDAQ |
Nov 21, 16:00
42.55
0.00 (0.00%)
After-Hours: 18:46
Avidity Biosciences Market Cap: 5.077B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.208B |
| November 19, 2024 | 5.160B |
| November 18, 2024 | 4.933B |
| November 15, 2024 | 5.032B |
| November 14, 2024 | 5.962B |
| November 13, 2024 | 6.264B |
| November 12, 2024 | 5.575B |
| November 11, 2024 | 5.622B |
| November 08, 2024 | 5.574B |
| November 07, 2024 | 5.668B |
| November 06, 2024 | 5.636B |
| November 05, 2024 | 5.380B |
| November 04, 2024 | 5.347B |
| November 01, 2024 | 4.995B |
| October 31, 2024 | 5.042B |
| October 30, 2024 | 5.157B |
| October 29, 2024 | 5.318B |
| October 28, 2024 | 5.455B |
| October 25, 2024 | 5.382B |
| October 24, 2024 | 5.387B |
| October 23, 2024 | 5.398B |
| October 22, 2024 | 5.633B |
| October 21, 2024 | 5.554B |
| October 18, 2024 | 5.999B |
| October 17, 2024 | 5.769B |
| Date | Value |
|---|---|
| October 16, 2024 | 5.819B |
| October 15, 2024 | 5.553B |
| October 14, 2024 | 5.554B |
| October 11, 2024 | 5.541B |
| October 10, 2024 | 5.258B |
| October 09, 2024 | 5.441B |
| October 08, 2024 | 5.509B |
| October 07, 2024 | 5.226B |
| October 04, 2024 | 5.624B |
| October 03, 2024 | 5.594B |
| October 02, 2024 | 5.603B |
| October 01, 2024 | 5.768B |
| September 30, 2024 | 5.461B |
| September 27, 2024 | 5.004B |
| September 26, 2024 | 4.985B |
| September 25, 2024 | 5.432B |
| September 24, 2024 | 5.202B |
| September 23, 2024 | 5.143B |
| September 20, 2024 | 5.258B |
| September 19, 2024 | 5.397B |
| September 18, 2024 | 5.276B |
| September 17, 2024 | 4.988B |
| September 16, 2024 | 4.936B |
| September 13, 2024 | 4.931B |
| September 12, 2024 | 4.884B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
360.87M
Minimum
Oct 27 2023
6.264B
Maximum
Nov 13 2024
1.444B
Average
985.36M
Median
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 10.56B |
| Vertex Pharmaceuticals Inc | 115.99B |
| Natera Inc | 22.37B |
| Entrada Therapeutics Inc | 676.37M |
| Alnylam Pharmaceuticals Inc | 31.84B |
Market Cap Related Metrics
| PS Ratio | 413.85 |
| Price to Book Value | 3.377 |
| Price | 42.55 |
| Earnings Yield | -6.79% |